
Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat
By Maggie FickLONDON (Reuters) -Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on top-selling medicines made in Europe from Novo Nordisk (NYSE:NVO)’s Wegovy for weight loss to Merck (NSE:PROR)’s cancer immunotherapy Keytruda.In conversations with U.S. officials, the pharmaceutical i ...